Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Amy Jensen-Smith
Observed name:
A. Jensen-Smith
OpenAlex ID:
A5085641237
BOXR1030, an anti-GPC3 CAR with exogenous GOT2 expression, shows enhanced T cell metabolism and improved anti-cell line derived tumor xenograft activity
2022
·
Taylor L. Hickman
, Eugene Choi
, et al.
·
PLoS ONE
·
33
PDF
Abstract 5469: Preclinical safety and efficacy of SOT109, an antibody-drug conjugate targeting cadherin 17 (CDH17) for the treatment of colorectal and other gastrointestinal tract tumors
2025
·
Nataliia Kalynovska
, Diana Hudecz
, et al.
·
Cancer Research
·
4
BOXR1030, an anti-GPC3 CAR with exogenous GOT2 expression, shows enhanced T cell metabolism and improved antitumor activity
2021
·
Taylor L. Hickman
, Eugene Choi
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
2
PDF
91P Targeting leucine-rich repeat-containing protein 15 (LRRC15): SOT106 antibody-drug conjugate for soft tissue sarcoma and osteosarcoma therapy
2025
·
M. Fojtů
, F. Jaburek
, et al.
·
ESMO Open
·
1
PDF
DUET-01: A first-in-human, phase 1/2 study of BOXR1030 in patients with advanced glypican-3-positive solid tumors.
2024
·
Ecaterina Elena Dumbrava
, Jonathan Robert Thompson
, et al.
·
Journal of Clinical Oncology
·
1
Abstract 1164: SOT106, a novel best-in-class antibody-drug conjugate targeting LRRC15, to treat sarcomas and other advanced solid cancers
2025
·
Michaela Fojtu
, Iva Valentová
, et al.
·
Cancer Research
273 Chimeric PGC1α expression in CAR-T cells improves metabolic function and anti-tumor efficacy in solid tumors
2024
·
Samyabrata Bhaduri
, Emily Kuiper
, et al.
·
Regular and Young Investigator Award Abstracts
Abstract 4012: SOT302: Dual expression of exogenous glutamine oxaloacetate transaminase (GOT2) and TP53-induced glycolysis and apoptosis regulator (TIGAR) enhance CAR T cell activity in preclinical solid tumor models
2024
·
Emily Kuiper
, Samyabrata Bhaduri
, et al.
·
Cancer Research
815 Combination with IL-15Rβγ superagonist, Nanrilkefusp alfa, enhances CAR T and BOXR T cell anti-tumor activity
2023
·
Emily Kuiper
, Kathleen Whiteman
, et al.
·
Regular and Young Investigator Award Abstracts
PDF
Abstract 5415: Glypican-3 immunohistochemistry precision, validation, and prevalence in selected solid tumors to identify target populations for CAR T cell therapy
2022
·
Glen J. Weiss
, Amy Jensen-Smith
, et al.
·
Cancer Research
Show more works
View as search
Works count:
10
Citation count:
41
H-index:
2
I10-index:
1
Year
Topic
Type